From chart-topping beats to a life-altering diagnosis, Ugandan hitmaker Didi faced viral stigma and chose to fight back, ...

Twenty-eight people have been diagnosed with HIV/AIDS, and one person died from HIV infection in Rajshahi in the past 11 ...

"It's one more piece of getting more people talking about HIV, getting tested for HIV and getting treated for HIV." ...

Since the human immunodeficiency virus (HIV) was identified in 1983, roughly 91.4 million people around the world have contracted the virus and an additional 44.1 million have died from related causes ...

The findings of this study are valuable as it demonstrates that when treatment is initiated during acute infection, HIV specific CD8 T cell responses are maintained long term and continued ...

If you have unprotected sex or you've got more than one partner, pre-exposure prophylaxis (PrEP) is your best defense against HIV, the virus that causes AIDS. When you take PrEP the right way, it's ...

Expanding reach to populations in Europe not currently using PrEP: Researchers will present the strategies that supported the recruitment of people in high-priority populations across France and the ...

Approval marks first and only twice-yearly option available in the United States for PrEP. HealthDay News — The U.S. Food and Drug Administration has approved Yeztugo (lenacapavir), an injectable ...

Sample blood collection tube with HIV test label on HIV infection screening test form. (Photo credit: Shutterstock.com / Room's Studio) A non-reactive HIV test result generally means good news – you ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugo ® (lenacapavir)—the company’s ...

Tema, May 27, GNA – Some HIV peer educators at the Tema General Hospital have urged persons living with HIV to religiously take their drugs to ensure their viral load becomes undetectable to protect ...